Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00958113 · ClinicalTrials.gov registry record
Autoimmune Thyroid Disease Genetic Study
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 199
- Enrollment target
NCT00958113 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 199 participants.
The verdict
NCT00958113 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 199 participants
- Enrollment target
Study Summary
The hypothesis of this project is that specific genes can be identified that contribute to genetic susceptibility to autoimmune thyroid disease (AITD) in different populations. The specific aim of this project is carry out one or more genomewide association studies (GWAS) to map and ultimately identify genes that confer susceptibility to AITD. AITD consists principally of Hashimoto's Thyroiditis (HT) and Graves' Disease (GD), characterized clinically generally by hypothyroidism and hyperthyroidism, respectively. Both HT and GD are autoimmune diseases characterized by infiltration of the thyroid by T and B cells that are reactive with thyroid antigens and by the production of thyroid autoantibodies (TAB). While there is some evidence that there may be genes specific to either GD or HT, other genes appear to be common to both, and some genes may furthermore be in common to susceptibility to other autoimmune diseases. Genes known to play a role in AITD include HLA, CTLA4, thyroglobulin (TG), THSR, and CD40, PTPN2, and PTPN22, several of which are also involved in susceptibility to other autoimmune diseases. All of these genes interact in a complex manner that has yet to be understood. Furthermore, it seems clear that relatively few of the genes involved in susceptibility to AITD have thus far been discovered.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 199 participants |
| Start Date | 2009-07 |
| Est. Completion | 2015-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00958113
The ClinicalTrials.gov registry entry for NCT00958113 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 199 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00958113 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00958113 about?
NCT00958113 is a clinical study titled "Autoimmune Thyroid Disease Genetic Study". The hypothesis of this project is that specific genes can be identified that contribute to genetic susceptibility to autoimmune thyroid disease (AITD) in different populations. The specific aim of this project is carry out one or more genomewide association studies (GWAS) to map and ultimately ident...
What is the current status of trial NCT00958113?
This trial is currently completed. The enrollment target is 199 participants. The study started on 2009-07. Estimated completion is 2015-05.
Who is sponsoring clinical trial NCT00958113?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.